Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-271.2%EBITDA Margin
VS
Market
Sector
Industry
History
$ 2.97Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -88.88M | -271.2% | $ 32.77M |
| 3/31/2025 | $ 26.84M | 85.58% | $ 31.36M |
| 12/31/2024 | $ -25.99M | -1016.46% | $ 2.56M |
| 9/30/2024 | $ -6.16M | -548.17% | $ 1.12M |
| 6/30/2024 | $ 27.3M | 4849.02% | $ 563K |
| 3/31/2024 | $ -120.35M | 0% | $ 0 |
| 12/31/2023 | $ -93.32M | 0% | $ 0 |
| 9/30/2023 | $ -104.02M | 0% | $ 0 |
| 6/30/2023 | $ -123.96M | 0% | $ 0 |
| 3/31/2023 | $ -89.72M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDA % stands at -1696.1%.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average EBITDA % has been -76.12%.
- The median EBITDA % for X4 PHARMACEUTICALS INC during this period was -548.17%
- X4 PHARMACEUTICALS INC reached its highest EBITDA % over the past 5 years at 4849.02%.
- The lowest EBITDA % recorded by X4 PHARMACEUTICALS INC in the same timeframe -1935.5%
X4 PHARMACEUTICALS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for X4 PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -50.88M ] / Revenues [ $ 3M ]
(=) EBITDA % [ -1696.1% ] XFOR - EBITDA Margin, Last 5 years
-1935.5%
Minimum
Dec 31, 2020
4849.02%
Maximum
Jun 30, 2024
-76.12%
Average
-548.17%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |